UK seeks to create healthy business environment with India
13 British pharma, life sciences and research organisations on a business visit to India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Rising above Neglect
In January last year, 13 pharmaceutical companies alongwith the US, the UK and the UAE governments; Bill & Melinda Gates…
Jubilant Biosys files IND with US-based Endo Pharmaceuticals
IND relates to a novel molecule targetting prostate cancer
DoP extends excise duty exemption on formulations under DPCO 2013
No extension in the deadlines set for price revision
World’s pharma development manufacturing base moving to India: IBEF
Generics exports growth of nearly 30 per cent enabling greater research spend
Ranbaxy allocates site for greenfield manufacturing facility in Malaysia
Agreement signed with Kulim Hi Tech Park
Biocon introduces novel biologic, ALZUMAb for psoriasis in India
ALZUMAb is being introduced in India by Biocon's Immuno Therapy Division
West-Coast Pharmaceutical Works to foray into nutraceutical segment
To launch the products in the western region of the country initially
Glenmark gets final ANDA approval for acamprosate
Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence
DPCO’13 impacts July growth
But growth back to double digits for products still out of price control
Lex Witness to organise 2nd Annual Pharma Legal & Compliance Summit 2013
Summit to be held in Mumbai on September 27, 2013
IPA organises clinical research conference
Conference attended by more than 100 participants had the theme ‘Practical Solution to Challenges in Clinical Research’
Pharmacovigilance: The way forward for India
Increasing drug recalls due to safety concerns are driving the need for robust pharmacovigilance systems, but India has not kept…
R&D focus is increasing in India
Shalini Gupta finds out more in an interview with Adefemi Adenuga, GlobalDatas Healthcare Analyst covering industry dynamics
SC asks centre to discuss clinical trial regulation with state/ UT health authorities
PIL petitioners to submit suggestions in two weeks; ISCR expresses concerns on slowdown of trial approvals
State/ UTs drug regulators await order to monitor drug price revision process
Karnataka state regulators write to state govt; Maharashtra and Gujarat gears up for action
Claris Lifesciences completes transfer of infusion biz in India and emerging markets to Otsuka JV
Receives a total cash consideration of Rs 1050 crores as a part of the transaction from Claris-Otsuka
Intas finalises corporate plans post IPO
Focuses on European market and setting up of a new R&D centre in Ahmedabad